Morgan Stanley maintains ‘Overweight' on BEL, lifts target to Rs 418 on long-term growth clarity
Morgan Stanley has reiterated its 'Overweight' rating on Bharat Electronics Ltd (BEL), raising the target price to ₹418. The brokerage highlighted BEL's execution edge, supply chain resilience, and robust order pipeline as key strengths.
In Q4FY25, BEL posted a 18.4% YoY growth in net profit, with margin improving to 30.8%. The company now targets 15–17.5% revenue CAGR over the next five years, followed by 20% growth thereafter.
Morgan Stanley noted BEL's FY26 order inflow guidance at ₹27,000 crore (excluding QR-SAM), and expects the company's 27% margin target to be comfortably achievable given current operating leverage. Compared to capital goods peers, BEL offers more consistent earnings and superior RoE, the note added.
Disclaimer: This article is based on the brokerage report by Morgan Stanley. It does not constitute investment advice.
Markets Desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Analyst revises Carvana stock price target ahead of earnings
Analyst revises Carvana stock price target ahead of earnings originally appeared on TheStreet. Hey, Jon Hamm, what are you up to? The veteran actor, who memorably portrayed Don Draper in "Mad Men" and is currently starring in "Your Friends and Neighbors" was caught off guard by a jogging neighbor in a TV ad for Carvana () . 💵💰Don't miss the move: Subscribe to TheStreet's free daily newsletter 💰 The ad, entitled "Excuses", rolled out last month and is the first of two commercial spots featuring Hamm In the 30-second spot, we see the actor trying to avoid attending a birthday party for his neighbor's dog by claiming his has to sell his car. The only problem, the ad tells us, is that the online used car retailer makes the process so fast and simple that Hamm's excuse unravels, especially since his car is already sold and loaded onto a Carvana hauler just a few feet away. So now he can go to the party, right? "I just sold my car," the actor replies. "What--are we going to walk?" Carvana's shares aren't walking; they're taking off at warp speed. The Tempe, Arizona-based company's stock has climbed 68% in 2025 and shares have soared 167% from a year ago. But it wasn't always that way. Carvana's stock tumbled 99% in 2022 as the company laid off staff. Morgan Stanley pulled its rating and price target on Carvana. More Automotive: 10,000 people join Tesla class action lawsuit over key issue EVs suffer surprising rejection in a crucial market Toyota makes surprising move to beat Tesla in key market New Constructs labeled Carvana a 'zombie company' and, after a much-heralded turnaround, short-selling firm Hindenburg Research declared Carvana's rebound "a mirage." "I think most companies that take a big swing generally have multiple near death experiences," Ernest Garcia III, CEO and co-founder of Carvana, said in April during an episode of the 20VC with Harry Stebbins podcast. "There are no stories of companies that make it with no volatility." "There are no stories of companies where people just cheer the whole time and it's like a standing slow clap that never ends," he added. "That's just not how it goes." Carvana went public in 2017 and when that happens, Garcia said, "it's just cold, it's ruthless, it's just results." "You have more moves than you think," he said. "When you find yourself with your back against the wall, you can find action that you might not have found otherwise. It makes risk a little less risky because when you find yourself in that spot, if you have problem solvers around. you can usually do more than people imagine." This could involve fundraising or finding a way to make dollars go further, or looking for ways to more efficient. "The lesson that I feel like I learned is you need to take risk to do something meaningful," Garcia said, "and I think risk is less risky than most people believe it is." Famed short-seller Jim Chanos had some harsh things to say about Carvana during 2025 Forbes Iconoclast Summit last month. 'Carvana is a misunderstood story," he said. "The Street believes it is an epic turnaround, but in fact, the company is still losing money. Although it is priced as a growth stock, the business is cyclical.' He said the company's gross margins are a product of aggressive accounting that inflates both unit economics and corporate profitability while excluding many components that other auto dealers typically include.'Carvana is making all this money in finance, not selling cars,' Chanos said. 'They are a subprime lender. Carvana is scheduled to report second quarter earnings on July 30. Citizens JMP raised the firm's price target on Carvana to $440 from $275 on July 2 and kept an outperform rating on the shares after assuming coverage of the name, according to The Fly. The firm said that Carvana created a consumer experience with an net promoter score of 69 by combining proprietary software to enable transparent selection of tens of thousands of vehicles, a nationwide logistics network, and a reconditioning service that enables it to price below brick and mortar dealers. Citizens JMP said that it believes Carvana can further grow while pushing toward its medium-term EBITDA margin target of 13.5%. On June 13 JPMorgan said that Carvana shares were "due for a pause" after materially outperforming peers year-to-date. The firm reduced estimates for the second quarter, saying recent prime deal disclosures suggest a slightly larger than expected gain on sale margin compression quarter-over-quarter. JPMorgan believes the second quarter could be the first time in several quarters that Carvana's EBITDA results are likely to miss expectations. The analyst kept an overweight rating on the shares with a $325 price revises Carvana stock price target ahead of earnings first appeared on TheStreet on Jul 2, 2025 This story was originally reported by TheStreet on Jul 2, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 hours ago
- Yahoo
The 3 areas of the stock market to buy as the dollar continues to plummet, Morgan Stanley says
The US dollar has tumbled this year, with the GOP budget bill threatening more declines. But Morgan Stanley sees the move in the dollar as a likely tailwind for the stock market. The bank sees it as a positive catalyst for companies in four sectors of the market. The dollar just wrapped up its worst half of a year since 1973, but the US currency's loss might be the stock market's gain. Morgan Stanley predicts that the dollar will continue depreciating throughout the year but it views this trend as a "substantial, under-appreciated tailwind" for stocks, one that could drive fresh earnings growth. It also laid out four sectors of the stock market the are set to benefit most from the dollar's string of declines. "The dollar is currently down approximately 11% from the January highs and is expected to fall another 7% by mid-2026 providing a substantial boost for multinational earnings," analyst Michelle Weaver said in a recent note. In Morgan Stanley's thesis, the key tailwind for stocks is companies with high exposure to foreign sales. A weaker US dollar makes currency conversions more favorable for overseas customers and makes US goods more attractive. Weaver also highlighted the translation effect, in which such companies can "earn a premium when exchanging revenues earned in foreign currencies into USD," which does not apply to competitors who only sell in the US. This creates an environment in which larger cap stocks are well-positioned to benefit. The note adds that the S&P 500, composed of the largest publicly traded US companies, typically derives roughly 40% its revenue from abroad. By contrast, the small-cap Russell 2000 sees about 22% of its revenue from overseas sales. "We have a broad preference for large-cap stocks given their higher-quality balance sheets, stronger pricing power, and stronger supplier negotiation power — the dollar dynamic further supports this view," she noted. For investors looking for specific sectors to focus on, Morgan Stanley has highlighted those with the highest foreign revenue exposure. First on the list is tech, which boasts more than 50%. The materials sector is next, with just over 40% exposure, followed by industrials, with 30%. Tech makes up the largest portion of the S&P 500, accounting for more than 30% of the benchmark index. That's likely part of why Morgan Stanley predicts it will rise even more as the dollar declines. As the bank said in a separate report this week, upward earnings revisions are the stock market's secret weapon for hitting new highs. "Morgan Stanley expects the S&P 500 to end the year at 6,500, implying a gain of about 5% from current record levels. With analysts growing more bullish on corporate earnings, the outlook points to a potentially sustainable growth trajectory." The "Big Beautiful Bill" that's moving through Congress is also expected to increase the national deficit by as much as $3.3 trillion, which could push the US dollar down even further. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
17 hours ago
- Business Insider
Citadel hires a chief medical officer as Ken Griffin pushes for 'peak performance'
Citadel employees are now not only being paid like elite athletes, but treated like them, too. The firm just hired former Morgan Stanley executive David Stark as its first-ever " chief medical officer," Business Insider has learned. The new role, which was announced Monday in an internal memo obtained by BI, is meant to "support peak performance" in employees at both the hedge fund and its sister market-making firm. The note said Stark, a neurologist who was previously in a similar role at Morgan Stanley, will start in September. "In this newly created role, David will be responsible for driving innovation in employee benefits and wellness to further enhance the employee experience and support peak performance of our colleagues," said Sjoerd Gehring, Citadel's chief people officer, who joined from Apple in November, said in the memo. This is the first in-house medical role for billionaire Ken Griffin's companies, according to a person with direct knowledge of the hire. Some offices have on-site medical clinics operated by third-party healthcare providers. Stark won't provide medical care, but will rework healthcare benefits, including concierge healthcare services, this person said. He'll also personalize health plans for the firm's employees. It's not only a new role for Citadel, but also the $5.7 trillion industry. Other hedge funds have had performance coaches, nutritionists, and even personal trainers on staff — Citadel has employed a global head of culinary for years, for example — but this is the first chief medical officer in the space, according to the person close to the Miami-based fund. It's another example of how the $66 billion hedge fund is more akin to an investment bank than its smaller asset management peers. Banks have long had these types of roles, in part to keep employees close to their desks so they can put in long hours with little interruption. Griffin has expressed admiration for the grueling work ethic required by many Wall Street institutions, specifically Goldman Sachs. Griffin, who has poached several Goldman executives to join his hedge fund and market-making firm, including Citadel Securities president Jim Esposito, said in 2020 at a talk with Goldman CFO John Waldron that leaders can't expect 9-to-5 schedules and "a great weekend." It's also not the first time the firm has offered employees extravagant work benefits. During the pandemic, Griffin rented out a hotel in Palm Beach as a makeshift trading floor so employees could work in a " bubble." He once treated Citadel and Citadel Securities employees and their families to a weekend at Disney World, which included a concert headlined by Coldplay. Even their summer internship this year started with a trip to the Four Seasons. According to the memo, Stark's background includes training as a pediatric neurologist at Harvard Medical School. Before his time at Morgan Stanley, he was a medical director at Mount Sinai Health System. Citadel views this as another way to help it stand out in the industry's talent war. "We believe this is a significant step forward, and one that will further differentiate Citadel as a place where exceptional people can achieve their highest potential," the memo said.
